porphyrin a

10/01/2012 - "109Pd labeled 5,10,15,20-tetrakis[4-carboxymethyleneoxyphenyl]porphyrin: a potential agent for targeted tumor therapy."
01/01/2012 - "These features make bare SiO(2)-attached cationic porphyrin a promising candidate for use in PDT for cancer treatment in which efficient (1)O(2) production at acidic pH and sensitizer deactivation at physiological pH are desirable. "
03/01/2007 - "The labeling of a porphyrin, a tumor-avid agent, with a beta-emitting radionuclide for evaluating its potential as an agent for targeted tumor therapy is reported. "
01/01/2009 - "The interaction between cationic porphyrin, a potential valuable anti-tumor and antibiotic drug, and human serum albumin (HSA) was investigated using spectroscopy methods. "
07/11/2015 - "A photosensitized and caspase-responsive multifunctional nanoprobe was designed by assembling a porphyrin, a folate targeting-motif and a dye-labelled peptide in a metal-organic framework (MOF) cage, which significantly increases the singlet oxygen quantum yield of porphyrin by 6.2 times, and achieves high efficient cancer therapy and in situ therapeutic monitoring with caspase-3 activation. "

05/03/2013 - "Siamese-twin porphyrin: a pyrazole-based expanded porphyrin of persistent helical conformation."
02/07/2011 - "Siamese-twin porphyrin: a pyrazole-based expanded porphyrin providing a bimetallic cavity."
02/12/2016 - "Oxidation of a nonaromatic Siamese-twin porphyrin, a pyrazole-containing expanded porphyrin with two porphyrinlike binding pockets, with a stoichiometric amount of the two-electron, two-proton oxidizing agent 2,3-dichloro-5,6-dicyano-1,4-benzochinone led to the formation of a single N(pz) -C(o-Ph) linkage between the pyrazole unit with a neighboring meso-phenyl group, forming a pyrazolo- [1,5-a]indole moiety. "

04/01/2021 - "To test this hypothesis, Eisenia fetida earthworms were exposed for 24 h to 30 nM rotenone, which causes mitochondrial dysfunction by generating high S-anion levels (known as the "VV-like phenotype"), and 10 μM porphyrin, a SOD2-like compound, which generates elevated HP levels (known as the "AA-like phenotype"). "

01/01/2019 - "Manganese(III) tetrakis(1-methyl-4-pyridyl) porphyrin, a superoxide dismutase mimetic, reduces disease severity in in vitro and in vivo models for dry-eye disease."

06/01/2001 - "Hyperglycemia-induced PTP inhibition and Syk phosphorylation were found to be completely prevented by TTFA, CCCP, or Mn(III)tetrakis (4-benzoic acid) porphyrin, a stable cell-permeable superoxide dismutase mimetic. "